Eisais Multi-Kinase VEGFR Inhibitor E7080 effective in animal models

Eisai’s Multikinase VEGFR Inhibitor E7080 has been shown to be effective in a mammary fat pad xenograft model of human breast cancer using MDA-MB-231

Alseres Rho inhibitor ALSE-100 shows efficacy in preclinical bone healing assays

Data presented at the Australian and New Zealand Bone and Mineral Society Annual Conference show Alseres’  Rho inhibitor ALSE-100 to show efficacy in preclinical bone healing assays

Combination of a sheddase inhibitor INCB3619 with lapatinib improves anti-tumor effect

Researchers have shown that the addition of sheddase inhibitor INCB3619 to lapatinib treated cells increases antitumor activity

Oncothyreon focus development on PI3K and HIF inhibitor

Oncothyreon have announced plans to prioritize resources on the clinical development of PI3K inhibitor  PX-478, HIF1 alpha inhibitor PX-866 and on process development and manufacturing of Stimuvax.